Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Netherlands

Marie Skłodowska-Curie Action · Running

RESPIRE-EXCEL Respiratory Precision Medicine PhD Training Network- Excellence through Systems Biology, Spatial and Single-cell Transcriptomics

Coordinator
Academisch Ziekenhuis Groningen, Netherlands
Runs
1 March 2025 to 28 February 2029
Status
Running
EU funding
€3.3m
Total cost
—
Partners
27 organisations in 11 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101169403

What the project is doing

In the project's own words, from its summary on CORDIS.

Asthma and COPD are prevalent, chronic respiratory diseases, with high incidence and societal costs. Current treatment is based on a ‘one-size-fits-all’ approach, that suppresses symptoms, but fails to achieve stable remission of disease. There is an urgent need to replace these generic treatments with precision medicine for asthma and COPD. This transition is hampered by the complexity of asthma and COPD on the one hand, and by the lack of an integrated, multidisciplinary approach to achieve progress towards precision medicine for these chronic respiratory disorders on the other hand.

The complexity of asthma and COPD is caused by multiple molecular mechanisms that independently contribute to the pathogenesis of disease. Their activity varies over time, and between patients, leading to substantial heterogeneity of asthma and COPD: identical clinical phenotypes can be caused by dissimilar molecular and cellular mechanisms, and requiring different treatments. The vision of RESPIRE-EXCEL is to achieve the transition to precision medicine in asthma and COPD by cross-sectoral and multi-disciplinary collaboration in respiratory research, drug discovery and development.

The success of this approach depends on respiratory scientists with the competence to combine expertise across disciplines, and the skills to collaborate with experts from industry, healthcare and academia. Therefore, the goal of RESPIRE-EXCEL is to enable the transition to precision medicine for asthma and COPD by training the next generation of translational and physician scientists with the skills, cross-sectoral competences and multidisciplinary knowledge to identify the molecular mechanisms of asthma and COPD, develop improved prognostic and diagnostic biomarkers to detect their activity in individual patients, and support the development of novel treatments that target individual disease mechanisms, aiming to achieve stable remission of disease in asthma and COPD through precision medicine.

Topics

Who is involved

OrganisationCityCountryRole
Academisch Ziekenhuis GroningenGroningenNetherlandsCoordinator
University of Technology SydneySydneyAustraliaAssociatedpartner
Lungs EuropeBruxelles / BrusselBelgiumAssociatedpartner
European Respiratory SocietyLausanneSwitzerlandAssociatedpartner
Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt GmbHNeuherbergGermanyParticipant
Ludwig-Maximilians-Universitaet MuenchenPlaneggGermanyAssociatedpartner
Universitaet Zu LuebeckLubeckGermanyAssociatedpartner
Universitatsklinikum Schleswig-HolsteinLübeckGermanyParticipant
Kobenhavns UniversitetKobenhavnDenmarkAssociatedpartner
Region HovedstadenHillerodDenmarkParticipant
Consorcio Para La Explotacion Del Centro Nacional De Analisis GenomicoBarcelonaSpainAssociatedpartner
Fundacio De Recerca Clinic Barcelona-Institut D Investigacions Biomediques August Pi I SunyerBarcelonaSpainParticipant
Omniscope Espana SLBarcelonaSpainParticipant
Universitat De BarcelonaBarcelonaSpainAssociatedpartner
Centre National De La Recherche Scientifique CNRSParisFranceParticipant
Universite Cote D'azurNiceFranceAssociatedpartner
Rijksuniversiteit GroningenGroningenNetherlandsAssociatedpartner
Umcg Research BVGroningenNetherlandsAssociatedpartner
Karolinska InstitutetStockholmSwedenParticipant
Lunds UniversitetLundSwedenAssociatedpartner
Stockholms UniversitetStockholmSwedenParticipant
Astrazeneca UK LimitedCambridgeUnited KingdomAssociatedpartner
European Lung FoundationSheffieldUnited KingdomAssociatedpartner
Imperial College of Science Technology and MedicineLondonUnited KingdomAssociatedpartner
The Chancellor Masters and Scholars of the University of CambridgeCambridgeUnited KingdomAssociatedpartner
University of LeicesterLeicesterUnited KingdomAssociatedpartner
Cellarity, IncSomervilleUnited StatesAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI